These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 34181499)

  • 1. Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment.
    Zhang Z; Zhang S; Zhang F; Zhang Q; Wei H; Xiu R; Zhao Y; Sui M
    Biol Trace Elem Res; 2024 Jan; 202(1):122-132. PubMed ID: 37097388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthropometric measures and arsenic methylation among pregnant women in rural northern Bangladesh.
    Smith TJS; Navas-Acien A; Baker S; Kok C; Kruczynski K; Avolio LN; Pisanic N; Randad PR; Fry RC; Goessler W; van Geen A; Buckley JP; Rahman MH; Ali H; Haque R; Shaikh S; Siddiqua TJ; Schulze K; West KP; Labrique AB; Heaney CD
    Environ Res; 2023 Oct; 234():116453. PubMed ID: 37343752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of arsenic exposure and arsenic metabolism with the risk of non-alcoholic fatty liver disease.
    Liu Y; Li W; Zhang J; Yan Y; Zhou Q; Liu Q; Guan Y; Zhao Z; An J; Cheng X; He M
    Int J Hyg Environ Health; 2024 Apr; 257():114342. PubMed ID: 38401403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia.
    Loh Z; Ashby M; Van Veldhuizen E; Li W; Chee A; Aung W; Lavrukhina Y; Mason G; Pelly T; Nedumannil R; Kosciejew S; Mokoonlall M; Lim J; Calov G; Butler L; Hillebrand P; Beekman A; Rathnasekara GK; Raj S; Zhang C; Yao Y; Iland H; Grigg A
    Br J Haematol; 2024 May; 204(5):1732-1739. PubMed ID: 38198799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery.
    Liu F; Deng Y; Wang A; Yang T; Ke H; Tang Y; Wu H; Chen H
    Expert Opin Drug Deliv; 2024 Jun; 21(6):867-880. PubMed ID: 38913024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical activity, body mass index and arsenic metabolism among Mexican women.
    Gamboa-Loira B; Cebrián ME; López-Carrillo L
    Environ Res; 2021 Apr; 195():110869. PubMed ID: 33581084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Association of Urinary Dimethylarsinic Acid (DMA
    Zhang K; Yin Y; Lv M; Zhang X; Zhang M; Cui J; Guan Z; Liu X; Liu Y; Gao Y; Yang Y
    Toxics; 2024 Jan; 12(1):. PubMed ID: 38251038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing arsenic trioxide's anticancer potential: Targeted nanocarriers for solid tumor therapy.
    Yang S; Raza F; Li K; Qiu Y; Su J; Qiu M
    Colloids Surf B Biointerfaces; 2024 Sep; 241():114014. PubMed ID: 38850742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cell-free DNA in patients with acute promyelocytic leukaemia treated with arsenic trioxide.
    Fujihara J; Nishimoto N; Takeshita H
    Ann Clin Biochem; 2024 Jul; 61(4):248-254. PubMed ID: 37944991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report.
    Emmons GS; Steingart RH; Stewart JA; Mertens WC
    J Med Case Rep; 2012 Oct; 6():355. PubMed ID: 23078653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.
    Hashimoto A; Tanaka Y; Ishikawa T; Shinzato I
    Clin Case Rep; 2021 Jul; 9(7):e04417. PubMed ID: 34322242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
    Ott A; Venkataraman V; Badran YR; Goldman R; Spasic S; Vyas DA; Amrein P; McAfee S; Brunner A; Fathi AT; Narayan R
    Clin Case Rep; 2021 May; 9(5):e04115. PubMed ID: 34026155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide.
    Hashimoto A; Tanaka Y; Shinzato I
    Clin Case Rep; 2021 Jul; 9(7):e04300. PubMed ID: 34322239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental fate of monosodium methanearsonate (MSMA)-Part 2: Modeling sequestration and transformation.
    Williams WM; Cheplick JM; Cohen SZ; Eldan M; Hoogeweg CG; Masue-Slowey Y; Vamshi R
    Integr Environ Assess Manag; 2024 Jun; ():. PubMed ID: 38923787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia.
    Cellini A; Salvalaggio A; Velasco R; Arnan M; Cacciavillani M; Riva M; Trentin L; Pomares H; Lessi F; Briani C
    Leuk Lymphoma; 2024 Aug; ():1-4. PubMed ID: 39138968
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy.
    Ghiaur A; Doran C; Gaman MA; Ionescu B; Tatic A; Cirstea M; Stancioaica MC; Hirjan R; Coriu D
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
    Zhao Q; Guo M; Hostetter TH; Chen H; Lin L; Hai X
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1173-1182. PubMed ID: 34181499
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide.
    Lu J; Yu K; Fan S; Liu W; Dong Z; Li J; Wang X; Hai X; Zhou J
    Toxicol Appl Pharmacol; 2019 Sep; 379():114687. PubMed ID: 31330140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Guo S; Wang X; Gao C; Wu Z; Chen H; Lin L; Guo M; Gao Y; Hai X
    Toxicol Lett; 2021 Sep; 347():78-85. PubMed ID: 33865921
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.